Kadcyla | search
Click here to view Kadcyla news from 60+ newspapers.
Bookmark or Share- Treatment Schedule for EBC | KADCYLA® (ado-trastuzumab emtansine)Read about the treatment schedule for KADCYLA® (ado-trastuzumab emtansine), a treatment for HER2+ early breast cancer. See Full Safety and Boxed Warnings for more information. For US Healthcare Professionals
- Helpful Links & Downloads | KADCYLA® (ado-trastuzumab emtansine)Access helpful links and downloads related to KADCYLA® (ado-trastuzumab emtansine), a treatment option for HER2+ early breast cancer. See Full Safety and Boxed Warnings for more information. For US Healthcare Professionals
- Understanding HER2+ early breast cancer - kadcylaKADCYLA is a prescription medicine used as an adjuvant (after surgery) treatment for HER2-positive early breast cancer when the patient has taken neoadjuvant (before surgery) treatment including a taxane and trastuzumab (Herceptin ®) and there is cancer remaining in the tissue removed during surgery.
- KADCYLA® (ado-trastuzumab emtansine) in HER2+ Breast CancerLearn about KADCYLA® (ado-trastuzumab emtansine), a treatment for certain patients with early or metastatic HER2+ breast cancer. See Full Safety and Boxed Warnings for more information. For US Healthcare Professionals
- Side Effects & Tips | KADCYLA® (ado-trastuzumab emtansine)Learn about possible side effects with KADCYLA® (ado-trastuzumab emtansine) for the treatment of HER2+ metastatic breast cancer. See Full Safety and Boxed Warnings for more information. For US Healthcare Professionals
More
